Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.
Identifieur interne : 000195 ( Main/Exploration ); précédent : 000194; suivant : 000196Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.
Auteurs : Mutlay Sayan [États-Unis] ; Ilkay Serbez [Turquie] ; Bilgehan Teymur [Turquie] ; Gokhan Gur [Turquie] ; Teuta Zoto Mustafayev [Turquie] ; Gorkem Gungor [Turquie] ; Banu Atalar [Turquie] ; Enis Ozyar [Turquie]Source :
- Frontiers in oncology [ 2234-943X ] ; 2020.
Abstract
Purpose
Magnetic resonance-guided radiation therapy (MRgRT) has been incorporated into a growing number of clinical practices world-wide, however, there is limited data on patient experiences with MRgRT. The purpose of this study was to prospectively evaluate patient tolerance of MRgRT using patient reported outcome questionnaires (PRO-Q).
Methods
Ninety patients were enrolled in this prospective observational study and treated with MRgRT (MRIdian Linac System, ViewRay Inc. Oakwood Village, OH, United States) between September 2018 and September 2019. Breath-hold-gated dose delivery with audiovisual feedback was completed as needed. Patients completed an in-house developed PRO-Q after the first and last fraction of MRgRT.
Results
The most commonly treated anatomic sites were the abdomen (47%) and pelvis (33%). Respiratory gating was utilized in 62% of the patients. Patients rated their experience as positive or at least tolerable with mean scores of 1.0-2.8. The most common complaint was the temperature in the room (61%) followed by paresthesias (57%). The degree of anxiety reported by 45% of the patients significantly decreased at the completion of treatment (mean score 1.54 vs. 1.36,
Conclusion
This evaluation of PROs indicates that MRgRT was well-tolerated by our patients. Patients' experience may further improve with adjustment of room temperature and noise reduction.
DOI: 10.3389/fonc.2020.01782
PubMed: 33072560
PubMed Central: PMC7537416
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.</title><author><name sortKey="Sayan, Mutlay" sort="Sayan, Mutlay" uniqKey="Sayan M" first="Mutlay" last="Sayan">Mutlay Sayan</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Serbez, Ilkay" sort="Serbez, Ilkay" uniqKey="Serbez I" first="Ilkay" last="Serbez">Ilkay Serbez</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Teymur, Bilgehan" sort="Teymur, Bilgehan" uniqKey="Teymur B" first="Bilgehan" last="Teymur">Bilgehan Teymur</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Gur, Gokhan" sort="Gur, Gokhan" uniqKey="Gur G" first="Gokhan" last="Gur">Gokhan Gur</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Zoto Mustafayev, Teuta" sort="Zoto Mustafayev, Teuta" uniqKey="Zoto Mustafayev T" first="Teuta" last="Zoto Mustafayev">Teuta Zoto Mustafayev</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Gungor, Gorkem" sort="Gungor, Gorkem" uniqKey="Gungor G" first="Gorkem" last="Gungor">Gorkem Gungor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Atalar, Banu" sort="Atalar, Banu" uniqKey="Atalar B" first="Banu" last="Atalar">Banu Atalar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Ozyar, Enis" sort="Ozyar, Enis" uniqKey="Ozyar E" first="Enis" last="Ozyar">Enis Ozyar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:33072560</idno><idno type="pmid">33072560</idno><idno type="doi">10.3389/fonc.2020.01782</idno><idno type="pmc">PMC7537416</idno><idno type="wicri:Area/Main/Corpus">000136</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000136</idno><idno type="wicri:Area/Main/Curation">000136</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000136</idno><idno type="wicri:Area/Main/Exploration">000136</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.</title><author><name sortKey="Sayan, Mutlay" sort="Sayan, Mutlay" uniqKey="Sayan M" first="Mutlay" last="Sayan">Mutlay Sayan</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Serbez, Ilkay" sort="Serbez, Ilkay" uniqKey="Serbez I" first="Ilkay" last="Serbez">Ilkay Serbez</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Teymur, Bilgehan" sort="Teymur, Bilgehan" uniqKey="Teymur B" first="Bilgehan" last="Teymur">Bilgehan Teymur</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Gur, Gokhan" sort="Gur, Gokhan" uniqKey="Gur G" first="Gokhan" last="Gur">Gokhan Gur</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Zoto Mustafayev, Teuta" sort="Zoto Mustafayev, Teuta" uniqKey="Zoto Mustafayev T" first="Teuta" last="Zoto Mustafayev">Teuta Zoto Mustafayev</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Gungor, Gorkem" sort="Gungor, Gorkem" uniqKey="Gungor G" first="Gorkem" last="Gungor">Gorkem Gungor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Atalar, Banu" sort="Atalar, Banu" uniqKey="Atalar B" first="Banu" last="Atalar">Banu Atalar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Ozyar, Enis" sort="Ozyar, Enis" uniqKey="Ozyar E" first="Enis" last="Ozyar">Enis Ozyar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author></analytic><series><title level="j">Frontiers in oncology</title><idno type="ISSN">2234-943X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Purpose</b></p><p>Magnetic resonance-guided radiation therapy (MRgRT) has been incorporated into a growing number of clinical practices world-wide, however, there is limited data on patient experiences with MRgRT. The purpose of this study was to prospectively evaluate patient tolerance of MRgRT using patient reported outcome questionnaires (PRO-Q).</p></div><div type="abstract" xml:lang="en"><p><b>Methods</b></p><p>Ninety patients were enrolled in this prospective observational study and treated with MRgRT (MRIdian Linac System, ViewRay Inc. Oakwood Village, OH, United States) between September 2018 and September 2019. Breath-hold-gated dose delivery with audiovisual feedback was completed as needed. Patients completed an in-house developed PRO-Q after the first and last fraction of MRgRT.</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>The most commonly treated anatomic sites were the abdomen (47%) and pelvis (33%). Respiratory gating was utilized in 62% of the patients. Patients rated their experience as positive or at least tolerable with mean scores of 1.0-2.8. The most common complaint was the temperature in the room (61%) followed by paresthesias (57%). The degree of anxiety reported by 45% of the patients significantly decreased at the completion of treatment (mean score 1.54 vs. 1.36, </p></div><div type="abstract" xml:lang="en"><p><b>Conclusion</b></p><p>This evaluation of PROs indicates that MRgRT was well-tolerated by our patients. Patients' experience may further improve with adjustment of room temperature and noise reduction.</p></div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33072560</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2234-943X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in oncology</Title><ISOAbbreviation>Front Oncol</ISOAbbreviation></Journal><ArticleTitle>Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.</ArticleTitle><Pagination><MedlinePgn>1782</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2020.01782</ELocationID><Abstract><AbstractText Label="Purpose" NlmCategory="UNASSIGNED">Magnetic resonance-guided radiation therapy (MRgRT) has been incorporated into a growing number of clinical practices world-wide, however, there is limited data on patient experiences with MRgRT. The purpose of this study was to prospectively evaluate patient tolerance of MRgRT using patient reported outcome questionnaires (PRO-Q).</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">Ninety patients were enrolled in this prospective observational study and treated with MRgRT (MRIdian Linac System, ViewRay Inc. Oakwood Village, OH, United States) between September 2018 and September 2019. Breath-hold-gated dose delivery with audiovisual feedback was completed as needed. Patients completed an in-house developed PRO-Q after the first and last fraction of MRgRT.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">The most commonly treated anatomic sites were the abdomen (47%) and pelvis (33%). Respiratory gating was utilized in 62% of the patients. Patients rated their experience as positive or at least tolerable with mean scores of 1.0-2.8. The most common complaint was the temperature in the room (61%) followed by paresthesias (57%). The degree of anxiety reported by 45% of the patients significantly decreased at the completion of treatment (mean score 1.54 vs. 1.36, <i>p</i> = 0.01). Forty-three percent of the patients reported some degree of disturbing noise which was improved considerably by use of music. All patients appreciated their active role during the treatment.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">This evaluation of PROs indicates that MRgRT was well-tolerated by our patients. Patients' experience may further improve with adjustment of room temperature and noise reduction.</AbstractText><CopyrightInformation>Copyright © 2020 Sayan, Serbez, Teymur, Gur, Zoto Mustafayev, Gungor, Atalar and Ozyar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sayan</LastName><ForeName>Mutlay</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serbez</LastName><ForeName>Ilkay</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teymur</LastName><ForeName>Bilgehan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gur</LastName><ForeName>Gokhan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoto Mustafayev</LastName><ForeName>Teuta</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gungor</LastName><ForeName>Gorkem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atalar</LastName><ForeName>Banu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozyar</LastName><ForeName>Enis</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Oncol</MedlineTA><NlmUniqueID>101568867</NlmUniqueID><ISSNLinking>2234-943X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MR-guided</Keyword><Keyword MajorTopicYN="N">MR-linac</Keyword><Keyword MajorTopicYN="N">patient tolerance</Keyword><Keyword MajorTopicYN="N">patient-reported outcomes</Keyword><Keyword MajorTopicYN="N">radiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>19</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33072560</ArticleId><ArticleId IdType="doi">10.3389/fonc.2020.01782</ArticleId><ArticleId IdType="pmc">PMC7537416</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phys Med. 2017 Dec;44:139-149</Citation><ArticleIdList><ArticleId IdType="pubmed">28242140</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Imaging Radiat Oncol. 2020 Feb;64(1):163-177</Citation><ArticleIdList><ArticleId IdType="pubmed">31646742</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Radiat Oncol. 2014 Jul;24(3):151-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24931085</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):933-941</Citation><ArticleIdList><ArticleId IdType="pubmed">30928360</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8433390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2014 Jul 08;106(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">25006191</ArticleId></ArticleIdList></Reference><Reference><Citation>J Public Health (Oxf). 2005 Sep;27(3):281-91</Citation><ArticleIdList><ArticleId IdType="pubmed">15870099</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumori. 2020 Feb 17;:300891620901752</Citation><ArticleIdList><ArticleId IdType="pubmed">32066345</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiat Oncol. 2019 Jun 3;14(1):92</Citation><ArticleIdList><ArticleId IdType="pubmed">31167658</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Radiat Oncol. 2018 Sep 05;14:1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">30406210</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2020 Jan;93(1105):20190655</Citation><ArticleIdList><ArticleId IdType="pubmed">31670569</ArticleId></ArticleIdList></Reference><Reference><Citation>Cureus. 2019 Dec 24;11(12):e6457</Citation><ArticleIdList><ArticleId IdType="pubmed">32025388</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Prefer Adherence. 2013;7:259-68</Citation><ArticleIdList><ArticleId IdType="pubmed">23569365</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2006 Sep;79 Spec No 1:S2-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16980682</ArticleId></ArticleIdList></Reference><Reference><Citation>Strahlenther Onkol. 2020 Aug;196(8):691-698</Citation><ArticleIdList><ArticleId IdType="pubmed">32002567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cureus. 2018 Feb 27;10(2):e2236</Citation><ArticleIdList><ArticleId IdType="pubmed">29719739</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cancer Res Ther. 2019 Jul-Sep;15(3):470-474</Citation><ArticleIdList><ArticleId IdType="pubmed">31169206</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2019 Nov;122:42-52</Citation><ArticleIdList><ArticleId IdType="pubmed">31614288</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Radiat Oncol. 2014 Jul;24(3):227-32</Citation><ArticleIdList><ArticleId IdType="pubmed">24931098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Turquie</li><li>États-Unis</li></country><region><li>New Jersey</li></region></list><tree><country name="États-Unis"><region name="New Jersey"><name sortKey="Sayan, Mutlay" sort="Sayan, Mutlay" uniqKey="Sayan M" first="Mutlay" last="Sayan">Mutlay Sayan</name></region></country><country name="Turquie"><noRegion><name sortKey="Serbez, Ilkay" sort="Serbez, Ilkay" uniqKey="Serbez I" first="Ilkay" last="Serbez">Ilkay Serbez</name></noRegion><name sortKey="Atalar, Banu" sort="Atalar, Banu" uniqKey="Atalar B" first="Banu" last="Atalar">Banu Atalar</name><name sortKey="Gungor, Gorkem" sort="Gungor, Gorkem" uniqKey="Gungor G" first="Gorkem" last="Gungor">Gorkem Gungor</name><name sortKey="Gur, Gokhan" sort="Gur, Gokhan" uniqKey="Gur G" first="Gokhan" last="Gur">Gokhan Gur</name><name sortKey="Ozyar, Enis" sort="Ozyar, Enis" uniqKey="Ozyar E" first="Enis" last="Ozyar">Enis Ozyar</name><name sortKey="Teymur, Bilgehan" sort="Teymur, Bilgehan" uniqKey="Teymur B" first="Bilgehan" last="Teymur">Bilgehan Teymur</name><name sortKey="Zoto Mustafayev, Teuta" sort="Zoto Mustafayev, Teuta" uniqKey="Zoto Mustafayev T" first="Teuta" last="Zoto Mustafayev">Teuta Zoto Mustafayev</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000195 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000195 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SanteMusiqueV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33072560
|texte= Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33072560" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SanteMusiqueV1
| This area was generated with Dilib version V0.6.38. |  |